. 2022 Jan 24;13(2):1045–1053. doi: 10.1002/jcsm.12920

Table 2.

Dose of physiotherapy prior to hyperinsulinaemic euglycaemic (HE) clamp

Daily physiotherapy before HE clamp	sPT	pPT	pPT+	P
Daily physiotherapy before HE clamp	n = 22	n = 8	n = 20	P
Mean duration of daily physiotherapy (min)	12.1 (6.5/13.8)	20.4 (17.3/23.8)	21.7 (17.6/24.8)	0.110
Days receiving protocol‐based physiotherapy within interventional trial before HE clamp (days)	0	13.5 (11.5/19.5)	15 (12.5/19.5)	0.823 ^a
Mean duration of added physiotherapeutic measures (whole body vibration and neuromuscular electrical stimulation)	0	0	16.1 (11.2/19.0)	—
Total daily time of muscle activating measures (min)	12.1 (6.5/13.8)	20.4 (17.3/23.8)	37.9 (29.6/46.0)	<0.001^*

Patients in the protocol‐based groups (pPT and pPT+) received a significantly higher dose of physiotherapy than patients in the standard physiotherapy group (sPT). When adding the time of whole body vibration and neuromuscular electrical stimulation, patients in the pPT+ group had significantly higher total time of muscle activating measures. All variables are presented as median (25th/75th percentile); P‐value determined by Kruskal–Wallis.

^{^a}

Significance calculated between protocol‐based physiotherapy (pPT) and protocol‐based physiotherapy combined with added measures group (pPT+) by Mann–Whitney U.

Significant differences.